Beyond tanning: why scientists study the melanocortin system

Skin colour is probably the most familiar context in which melanocortins come up. That association comes from real biology: melanocortin signalling is involved in the way melanocytes control pigment production, a process studied for many years.

Look beyond the skin, though, and the system gets considerably more varied. Different types of melanocortin receptors are found in tissues throughout the body, where they respond to naturally produced signalling molecules. Which receptor is involved makes a considerable difference. Pigmentation is one area; adrenal hormone production and energy balance are others.

The result is a signalling system that turns up in several otherwise quite different areas of physiology.

One system, five receptors

Scientists have identified five members of the melanocortin receptor family: MC1R, MC2R, MC3R, MC4R and MC5R. They are GPCRs, or G protein-coupled receptors. These are cell-surface receptors that pass information from an external signal into the cell.

Their functions vary.

The best-known association for MC1R is pigmentation. MC2R occupies a rather different place in the family. ACTH is its physiological agonist, and much of its established biology concerns adrenal steroid production. MC3R and MC4R are involved in energy balance. MC5R has been linked to exocrine gland function, although research into its wider biology continues.

These roles are not strict boundaries. A receptor may occur in different tissues and take part in more than the process it is best known for. MC1R makes the point quite well. Most people encounter it in the context of pigmentation, but studies have also examined its signalling in relation to oxidative stress and cellular responses to DNA damage.

How melanocortin signalling affects pigmentation

A useful place to start is α-melanocyte-stimulating hormone, better known as α-MSH. In skin, it interacts with MC1R receptors found on melanocytes – the cells that produce melanin. Once this receptor is activated, the balance of pigment production can shift towards eumelanin, the brown-black type of melanin.

Sunlight brings another part of the pathway into play. UVB can damage DNA in keratinocytes, and the cellular response involves p53 as well as the POMC gene. POMC itself is a precursor: the cell processes it into smaller signalling molecules, one of which is α-MSH. This provides a biological link between UV exposure, MC1R signalling and changes in pigmentation.

The picture varies from person to person because MC1R itself varies. Some genetic variants affect how well the receptor functions and are associated with differences in skin and hair colour. Certain variants also weaken signalling that normally favours eumelanin. So even this relatively familiar part of melanocortin biology involves several moving pieces – genes, signalling molecules, receptors and the cells responding to them.

Why synthetic analogues are used in research

Natural peptides are not always the most practical molecules to work with in an experiment. Sometimes a modified version gives researchers a better way to examine a receptor or compare how a change in structure affects signalling. Stability can change. Receptor activity can change too.

That approach has produced a number of synthetic melanocortin analogues. Melanotan II, or MTII, is one of them.

MTII is a cyclic synthetic peptide related to α-MSH. It keeps a sequence that is important for melanocortin receptor activity, but it is not simply a copy of the natural hormone. Its modified structure and cyclisation make it a distinct molecule.

There is another detail that matters experimentally. MTII is not highly selective for a single melanocortin receptor. Pharmacological studies have found agonist activity at MC1R, MC3R, MC4R and MC5R. This allows it to be used in experiments examining melanocortin signalling across several receptor subtypes, but interpretation depends on the model. If more than one of those receptors is present, an observed response cannot be attributed to a particular receptor without additional evidence.

Synthetic melanocortin ligands are used in work ranging from receptor-characterisation experiments to structural studies and screening. A 2024 review of recommended melanocortin receptor research tools includes Melanotan II among the established synthetic ligands used to investigate this receptor family.

For laboratories working with these experimental models, research suppliers provide synthetic analogues in different laboratory formats, including options for researchers looking to purchase Melanotan 2. Such materials are used as research compounds rather than approved medicines, and findings depend on the model, receptor system and experimental conditions being studied.

The melanocortin system reaches beyond skin

MC3R and MC4R take melanocortin research into a quite different area.

Both are involved in the regulation of energy balance, with MC4R receiving particular attention in research on appetite and energy expenditure. In the brain, α-MSH released by POMC neurons can activate MC4R-containing neural circuits involved in the regulation of food intake. Other neurons produce AgRP, which opposes melanocortin signalling at these receptors.

Human genetics has strengthened the evidence that this pathway matters physiologically. Disruption of MC4R signalling is a well-established cause of monogenic obesity, although the relationship between individual genetic variants, appetite and energy intake can be complex. A recent systematic review of one common MC4R-associated variant, for example, found evidence for an association with appetite under one statistical model but not a clear association with measured energy intake.

This is quite far removed from pigmentation, even though both areas sit within the same receptor family.

It also shows why the phrase “melanocortin effect” can be misleading. The biological question depends heavily on which receptor is being studied, where that receptor is expressed and which ligand is activating it.

Why receptor selectivity matters

A compound that strongly activates one receptor can be useful for answering a relatively focused question. A ligand that interacts with several receptor subtypes can answer different questions, but interpreting the results becomes harder.

Melanotan II illustrates the latter case.

It has agonist activity at four melanocortin receptor subtypes rather than being selective for MC1R alone. In a cell system expressing MC1R, that may not create much ambiguity. In a more complex model containing several melanocortin receptors, the same assumption would be much harder to make.

There are several ways to work around this problem in the lab. One experiment might compare selective agonists and antagonists. Another may use cells that differ in receptor expression, or pair pharmacological testing with genetic methods. More recently, structural techniques have opened a different window on the same question. Cryo-electron microscopy, for example, can show how a melanocortin ligand sits within a receptor at molecular resolution.

So broad activity is not automatically an advantage or a disadvantage. It changes the experiment that can be performed and the conclusions that can reasonably be drawn from it.

Different experiments answer different questions

There is no single type of experiment behind what we call melanocortin research. Some studies measure receptor binding or signalling in cultured cells. Others use animal models. Human genetics and clinical research provide different kinds of evidence again, and each comes with its own limits.

A binding assay answers a fairly narrow question: does the molecule interact with the receptor under the conditions being tested? Cell experiments can go further and follow the signalling that comes next. Animal models introduce interactions between tissues and whole-body physiology. Human studies operate at another level altogether.

Moving from one model to the next does not simply add more evidence to the same result. The question changes, and so do the variables.

This matters when synthetic research compounds are involved. Receptor activity on its own says nothing about whether a compound has a medical benefit. Findings in animals also need to stay in that context unless human evidence supports the same conclusion. Even within the melanocortin family, an observation involving one receptor should not be assumed to apply to another.

The reason scientists keep returning to this system is the range of questions it allows them to ask. Its five receptors appear in distinct areas of biology, from pigmentation to energy regulation, and synthetic ligands can help separate one part of that signalling from another. Which receptor is active, where it is expressed and what experimental model is being used often matter more than the broad label “melanocortin”.

Scientific sources: